ÇÁ·Î±×·¥


Àλ縻
     
Á¦1ºÎ - ±âÃÊ°úÇÐÀÚ¸¦ À§ÇÑ ÀÓ»óÁ¾¾çÇÐ
Session 1 09:00-10:15
1) ¾ÏÀÇ Áø´Ü, º´±â¼³Á¤, Ä¡·áÀÇ ¿øÄ¢ ¼Û±³¿µ (°¡Å縯ÀÇ´ë)
2) ¹æ»ç¼±Ä¡·áÀÇ ¿øÄ¢ °­Çöö (¼­¿ïÀÇ´ë)
3) º´¸® ¹ÙÀÌ¿À¸¶Ä¿ °Ë»çÀÇ ÀÌÇØ ¾È¼ö¹Î (¼º±Õ°üÀÇ´ë)
     
Break 10:15-10:35
     
Session 2 10:35-11:50
1) Ç×¾ÏÄ¡·áÀÇ ¿øÄ¢ ±èâ°ï (¿¬¼¼ÀÇ´ë)
2) ¾Ï ÀÓ»ó½ÃÇèÀÇ ÀÌÇØ I (Phase, design, endpoint) ±èÇüµ· (¿ï»êÀÇ´ë)
3) ¾Ï ÀÓ»ó½ÃÇèÀÇ ÀÌÇØ II (RECIST, CTCAE) À°Á¤È¯ (¼­¿ïÀÇ´ë)
     
Lunch Break 11:50-13:00
     
Á¦2ºÎ - ¾Ï ¿¬±¸¸¦ À§ÇÑ ¸é¿ªÇÐ/À¯ÀüüÇÐÀÇ ±âÃÊ
¾Ï ¿¬±¸¸¦ À§ÇÑ ¸é¿ªÇÐÀÇ ±âÃÊ 13:00-14:40
1) Understanding anti-tumor immune responses ½ÅÀÇö (KAIST)
2) PD-1, T cell exhaustion, and immune checkpoint inhibitors ÀÓ¼¼Áø (¼º±Õ°üÀÇ´ë)
3) TIGIT and LAG3, targets of novel immune checkpoint inhibitors ¹ÚÀ± (KIST)
4) Current trends in personalized cancer vaccines ÀÓ¿ÁÀç (Ƽ½ì·ÎÁö)
     
Break 14:40-15:00
     
¾Ï ¿¬±¸¸¦ À§ÇÑ À¯ÀüüÇÐÀÇ ±âÃÊ 15:00-16:40
1) Epigenomic and epitranscriptomic alterations in cancer Á¶¼º¿± (¼­¿ïÀÇ´ë)
2) Real world applications of whole-genome sequencing ÀÌÁ¤¼® (KAIST)
3) Current and future applications of circulating tumor DNA assays ±è¿µ°ï (¼º±Õ°üÀÇ´ë)
4) Navigating the cancer evolution using single-cell genomics ±è±ÔÅ (¾ÆÁÖÀÇ´ë)